Modulating Immunogenicity and Reactogenicity in mRNA-Lipid Nanoparticle Vaccines through Lipid Component Optimization
ACS Nano · 05.08.2025 · 19 (30) · 27977-28001
DOI: 10.1021/acsnano.5c10648 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 23.07.2025. Verfasst von Yoshino Kawaguchi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine Creation Group, BIKEN Innovative Vaccine Research Alliance Laboratories, Research Institute for Microbial Diseases, The University of Osaka, …. Hauptthemen laut MEDLINE: Nanoparticles, RNA, Messenger, Lipids, mRNA Vaccines. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Osaka University, Takeda Science Foundation, BIKEN Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vaccine Creation Group, BIKEN Innovative Vaccine Research Alliance Laboratories, Research Institute for Microbial Diseases, The University of Osaka, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
- Department of Pharmacokinetics and Biopharmaceutics, Graduate School of Biomedical Sciences, Tokushima University, 1-78-1 Sho-machi, Tokushima, Tokushima 770-8505, Japan.
- The Research Foundation for Microbial Diseases of Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
- Laboratory of DDS Design and Drug Disposition, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai, Miyagi 980-8578, Japan.
- Center for Advanced Modalities and DDS, The University of Osaka, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
- Laboratory of Virus Control, Research Institute for Microbial Diseases, The University of Osaka, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
ORCID-Profile: Tatsuhiro Ishida, Hidetaka Akita, Yasuo Yoshioka
Förderung
- Osaka University
- Takeda Science Foundation
- BIKEN Foundation
- Japan Agency for Medical Research and Development
- Nippon Foundation
- Japan Society for the Promotion of Science
Zitieren
APA
Kawaguchi, Y., Kimura, M., Karaki, T., Tanaka, H., Ono, C., Ishida, T., Matsuura, Y., Hirai, T., Akita, H., Shimizu, T., & Yoshioka, Y. (2025). Modulating Immunogenicity and Reactogenicity in mRNA-Lipid Nanoparticle Vaccines through Lipid Component Optimization. ACS Nano, 19(30), 27977-28001. https://doi.org/10.1021/acsnano.5c10648
Vancouver
Kawaguchi Y, Kimura M, Karaki T, Tanaka H, Ono C, Ishida T, et al. Modulating Immunogenicity and Reactogenicity in mRNA-Lipid Nanoparticle Vaccines through Lipid Component Optimization. ACS Nano. 2025;19(30):27977-28001. doi:10.1021/acsnano.5c10648
BibTeX
@article{Kawaguchi2025,
author = {Kawaguchi, Yoshino and Kimura, Mari and Karaki, Tatsuya and Tanaka, Hiroki and Ono, Chikako and Ishida, Tatsuhiro and Matsuura, Yoshiharu and Hirai, Toshiro and Akita, Hidetaka and Shimizu, Taro and Yoshioka, Yasuo},
title = {Modulating Immunogenicity and Reactogenicity in mRNA-Lipid Nanoparticle Vaccines through Lipid Component Optimization},
journal = {ACS Nano},
year = {2025},
volume = {19},
number = {30},
pages = {27977--28001},
doi = {10.1021/acsnano.5c10648}
}
EUVIMED